Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy Comparison of Ivermectin 1% Topical Cream Associated With Doxycycline 40 mg Modified Release (MR) Capsules Versus Ivermectin 1% Topical Cream Associated With Placebo in the Treatment of Severe Rosacea

NCT03075891 is registered in ClinicalTrials.gov with Galderma R&D as lead sponsor.

NCT NCT03075891
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03075891 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy Comparison of Ivermectin 1% Topical Cream Associated With Doxycycline 40 mg Modified Release (MR) Capsules Versus Ivermectin 1% Topical Cream Associated With Placebo in the Treatment of Severe Rosacea
Lead sponsor
Galderma R&D
Phase
Phase 4
Overall status
Completed
Start date
July 5, 2017
Completion date
February 8, 2018
Enrollment
273 (actual)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

rosacea